TNXP

TONIX PHARMACEUTICALS HLDG C

TNXP·890260839·US·Common Stock·Healthcare - Biotechnology-13D/G

TNXP (TONIX PHARMACEUTICALS HLDG C) is held by 56 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($13.3M), VANGUARD CAPITAL MANAGEMENT LLC ($7.1M), CITADEL ADVISORS LLC ($6.4M). Net institutional sentiment: Mixed.

56
Holders
Avg rating(13 Elite)
$59.4M
Total Value
67% (61)
Fund Consensus
36 buying - 18 selling
TNXPSmart Money Verdict
View all
Held by 56 funds
13 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC5.6%Jun 15, 2026
InsiderTETaylor Carolyn E.Buy $15KJun 12, 2026
ActivistSISirenia Capital Management LP8.8%May 15, 2026
InsiderLSLEDERMAN SETHBuy $63KMar 31, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderLSLEDERMAN SETHBuy $223KMar 18, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.7%Jan 21, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.9.2%Dec 31, 2025
InsiderTETaylor Carolyn E.Buy $15KAug 21, 2025
InsiderTJTreco JamesBuy $9KAug 20, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
968,177(+9.4%)$13.3M0.0%-50.46%
31
New
518,650$7.1M0.0%-10.11%
38
New
468,712$6.4M0.0%-10.11%
38
Increased
313,291(+15.2%)$4.3M0.0%-47.91%
31
Increased
313,082(+68.9%)$4.3M0.0%-16.76%
40
Increased
231,678(+153.3%)$3.2M0.0%-23.53%
43
Increased
230,607(+20.2%)$3.2M0.0%-50.96%
31
Increased
219,673(+857.4%)$3M0.0%-16.41%
43
Increased
161,208(+705.2%)$2.2M0.0%-11.60%
42
Decreased
125,414(-79.8%)$1.7M0.0%-20.80%
0
Decreased
100,134(-42.7%)$1.4M0.0%-61.91%
0
Increased
94,561(+1.2%)$1.3M0.0%-33.69%
26
New
84,270$1.2M0.0%-10.11%
35
New
78,627$1.1M0.0%-10.11%
35
Increased
60,958(+101.1%)$838,1730.0%-18.07%
40
Increased
53,055(+97.9%)$729,5060.0%-26.44%
40
Increased
30,426(+26.4%)$418,3520.0%-54.03%
30
Decreased
29,790(-10.8%)$409,6130.0%-57.64%
0
Decreased
29,579(-0.3%)$406,7110.0%-41.57%
0
New
17,410$239,3880.0%-10.11%
32

Showing 1-20 of 61

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used